Network Controllability Analysis of Three Multiple-myeloma Patient Genetic Mutation Datasets

2020 ◽  
Author(s):  
Jose Angel Sanchez Martin ◽  
Ion Petre
Keyword(s):  
Drug Targets ◽  
Genetic Mutation ◽  
Directed Network ◽  
Initial State ◽  
Final State ◽  
Multiple Myeloma Patient ◽  
Protein Protein Interaction ◽  
Arbitrary Initial State ◽  
Protein Protein Interaction Networks ◽  
Network Controllability

Network controllability focuses on the concept of driving the dynamical system associated to a directed network of interactions from an arbitrary initial state to an arbitrary final state, through a well-chosen set of input functions applied in a minimal number of so-called input nodes. In earlier studies we and other groups demonstrated the potential of applying this concept in medicine. A directed network of interactions may be built around the main known drivers of the disease being studied, and then analysed to identify combinations of drug targets controlling survivability-essential genes in the network. This paper takes the next step and focuses on patient data. We demonstrate that comprehensive protein-protein interaction networks can be built around patient genetic data, and that network controllability can be used to identify possible personalised drug combinations. We discuss the algorithmic methods that can be used to construct and analyse these networks.

Network Controllability Analysis of Three Multiple-myeloma Patient Genetic Mutation Datasets

2020 ◽  
Vol 175 (1-4) ◽  
pp. 281-299 ◽  
Author(s):  
Jose Angel Sanchez Martin ◽  
Ion Petre
Keyword(s):  
Drug Targets ◽  
Genetic Mutation ◽  
Directed Network ◽  
Initial State ◽  
Final State ◽  
Multiple Myeloma Patient ◽  
Protein Protein Interaction ◽  
Arbitrary Initial State ◽  
Protein Protein Interaction Networks ◽  
Network Controllability

Network controllability focuses on the concept of driving the dynamical system associated to a directed network of interactions from an arbitrary initial state to an arbitrary final state, through a well-chosen set of input functions applied in a minimal number of so-called input nodes. In earlier studies we and other groups demonstrated the potential of applying this concept in medicine. A directed network of interactions may be built around the main known drivers of the disease being studied, and then analysed to identify combinations of drug targets controlling survivability-essential genes in the network. This paper takes the next step and focuses on patient data. We demonstrate that comprehensive protein-protein interaction networks can be built around patient genetic data, and that network controllability can be used to identify possible personalised drug combinations. We discuss the algorithmic methods that can be used to construct and analyse these networks.

Network-based methods for predicting essential genes or proteins: a survey

2019 ◽  
Vol 21 (2) ◽  
pp. 566-583 ◽  
Author(s):  
Xingyi Li ◽  
Wenkai Li ◽  
Min Zeng ◽  
Ruiqing Zheng ◽  
Min Li
Keyword(s):  
Drug Targets ◽  
Rapid Development ◽  
Essential Genes ◽  
Biological Information ◽  
Future Research ◽  
Dynamic Features ◽  
Laboratory Methods ◽  
Protein Protein Interaction ◽  
Protein Protein Interaction Networks ◽  
Topological Characteristics

Abstract Genes that are thought to be critical for the survival of organisms or cells are called essential genes. The prediction of essential genes and their products (essential proteins) is of great value in exploring the mechanism of complex diseases, the study of the minimal required genome for living cells and the development of new drug targets. As laboratory methods are often complicated, costly and time-consuming, a great many of computational methods have been proposed to identify essential genes/proteins from the perspective of the network level with the in-depth understanding of network biology and the rapid development of biotechnologies. Through analyzing the topological characteristics of essential genes/proteins in protein–protein interaction networks (PINs), integrating biological information and considering the dynamic features of PINs, network-based methods have been proved to be effective in the identification of essential genes/proteins. In this paper, we survey the advanced methods for network-based prediction of essential genes/proteins and present the challenges and directions for future research.

scholarly journals Network controllability solutions for computational drug repurposing using genetic algorithms

2021 ◽  
Author(s):  
Victor-Bogdan Popescu ◽  
Krishna Kanhaiya ◽  
Iulian Nastac ◽  
Eugen Czeizler ◽  
Ion Petre
Keyword(s):  
Genetic Algorithms ◽  
Drug Targets ◽  
Interaction Network ◽  
Drug Repurposing ◽  
Small World ◽  
Specific Protein ◽  
Scale Free ◽  
Protein Protein Interaction ◽  
External Interventions ◽  
Network Controllability

Abstract Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximize its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We show how our algorithm identifies a number of potentially efficient drugs for breast, ovarian, and pancreatic cancer. We demonstrate our algorithm on several benchmark networks from cancer medicine, social networks, electronic circuits, and several random networks with their edges distributed according to the Erdös-Rényi, the scale-free, and the small world properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches.

scholarly journals Drug Target Protein-Protein Interaction Networks: A Systematic Perspective

2017 ◽  
Vol 2017 ◽  
pp. 1-13 ◽  
Author(s):  
Yanghe Feng ◽  
Qi Wang ◽  
Tengjiao Wang
Keyword(s):  
Protein Interactions ◽  
Drug Target ◽  
Drug Targets ◽  
Protein Interaction Networks ◽  
Interaction Networks ◽  
Ppi Network ◽  
Protein Protein Interactions ◽  
Protein Protein Interaction ◽  
Topological Features ◽  
Protein Protein Interaction Networks

The identification and validation of drug targets are crucial in biomedical research and many studies have been conducted on analyzing drug target features for getting a better understanding on principles of their mechanisms. But most of them are based on either strong biological hypotheses or the chemical and physical properties of those targets separately. In this paper, we investigated three main ways to understand the functional biomolecules based on the topological features of drug targets. There are no significant differences between targets and common proteins in the protein-protein interactions network, indicating the drug targets are neither hub proteins which are dominant nor the bridge proteins. According to some special topological structures of the drug targets, there are significant differences between known targets and other proteins. Furthermore, the drug targets mainly belong to three typical communities based on their modularity. These topological features are helpful to understand how the drug targets work in the PPI network. Particularly, it is an alternative way to predict potential targets or extract nontargets to test a new drug target efficiently and economically. By this way, a drug target’s homologue set containing 102 potential target proteins is predicted in the paper.

scholarly journals Development of a Novel High-Throughput Screen and Identification of Small-Molecule Inhibitors of the Gα–RGS17 Protein–Protein Interaction Using AlphaScreen

2011 ◽  
Vol 16 (8) ◽  
pp. 869-877 ◽  
Author(s):  
Duncan I. Mackie ◽  
David L. Roman
Keyword(s):  
Small Molecule ◽  
High Throughput ◽  
Protein Interaction ◽  
High Throughput Screening ◽  
Drug Targets ◽  
Screening Method ◽  
Fold Increase ◽  
Rgs Proteins ◽  
High Throughput Screen ◽  
Protein Protein Interaction

In this study, the authors used AlphaScreen technology to develop a high-throughput screening method for interrogating small-molecule libraries for inhibitors of the Gαo–RGS17 interaction. RGS17 is implicated in the growth, proliferation, metastasis, and the migration of prostate and lung cancers. RGS17 is upregulated in lung and prostate tumors up to a 13-fold increase over patient-matched normal tissues. Studies show RGS17 knockdown inhibits colony formation and decreases tumorigenesis in nude mice. The screen in this study uses a measurement of the Gαo–RGS17 protein–protein interaction, with an excellent Z score exceeding 0.73, a signal-to-noise ratio >70, and a screening time of 1100 compounds per hour. The authors screened the NCI Diversity Set II and determined 35 initial hits, of which 16 were confirmed after screening against controls. The 16 compounds exhibited IC50 <10 µM in dose–response experiments. Four exhibited IC50 values <6 µM while inhibiting the Gαo–RGS17 interaction >50% when compared to a biotinylated glutathione-S-transferase control. This report describes the first high-throughput screen for RGS17 inhibitors, as well as a novel paradigm adaptable to many other RGS proteins, which are emerging as attractive drug targets for modulating G-protein-coupled receptor signaling.

scholarly journals In vivo interactome profiling by enzyme‐catalyzed proximity labeling

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yangfan Xu ◽  
Xianqun Fan ◽  
Yang Hu
Keyword(s):  
State Of The Art ◽  
Catalytic Efficiency ◽  
Biological Processes ◽  
Protein Protein Interaction ◽  
Current State ◽  
Protein Interactome ◽  
Potential Applications ◽  
Protein Protein Interaction Networks ◽  
Temporal And Spatial

AbstractEnzyme-catalyzed proximity labeling (PL) combined with mass spectrometry (MS) has emerged as a revolutionary approach to reveal the protein-protein interaction networks, dissect complex biological processes, and characterize the subcellular proteome in a more physiological setting than before. The enzymatic tags are being upgraded to improve temporal and spatial resolution and obtain faster catalytic dynamics and higher catalytic efficiency. In vivo application of PL integrated with other state of the art techniques has recently been adapted in live animals and plants, allowing questions to be addressed that were previously inaccessible. It is timely to summarize the current state of PL-dependent interactome studies and their potential applications. We will focus on in vivo uses of newer versions of PL and highlight critical considerations for successful in vivo PL experiments that will provide novel insights into the protein interactome in the context of human diseases.

Sign in / Sign up

Export Citation Format

Share Document